Therapeutic potential of boosting astrocytic Nrf2-mediated antioxidant signalling in combating white matter damage, amyloid pathology and cognitive deficits caused by chronic cerebral hypoperfusion

Project Details

StatusFinished
Effective start/end date1/09/1421/04/19

Funding

  • UK-based charities: £329,200.00